Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and ro13-9904

levofloxacin has been researched along with ro13-9904 in 84 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(ro13-9904)		Trials
(ro13-9904)		Recent Studies (post-2010) (ro13-9904)
4,3465812,2096,8157982,755

Research

Studies (84)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (8.33)18.2507
2000's25 (29.76)29.6817
2010's35 (41.67)24.3611
2020's17 (20.24)2.80

Authors

AuthorsStudies
Dunbar, L; File, TM; Kohler, R; Kojak, C; Player, R; Rubin, A; Segreti, J; Williams, RR1
Kahn, J; Mauriz, Y; Ogilvie, P; Thornsberry, C1
Tuohy, M; Washington, JA1
Norrby, SR; Petermann, W; Salewski, E; Vetter, N; Willcox, PA1
Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G1
Caldelari, I; Entenza, JM; Glauser, MP; Moreillon, P1
Léophonte, P; Veyssier, P1
Bell, T; Benenson, R; Kellogg, J; Manzella, J; Pellerin, G; Pope, D; Robertson, M1
Bagilet, D; Diab, M; Javkin, E; Kalbermatter, V1
Bosso, JA; Enzweiler, KA; Friedrich, LV; Hoban, D; Wagner, D; White, RL1
Bahal, N; Frank, E; Freitag, S; Kahn, JB; Kinasewitz, G; Liu, J; Moran, GJ; Olson, WH; Oross, MP; Reichl, V; Tennenberg, A; Wiesinger, BA1
Appelbaum, PC; Bozdogan, B; Browne, FA; Clark, C; Dewasse, BE; Jacobs, MR1
Castellano, G; Morillasa, JD; Pérez Carreras, M; Solís, JA; Tomás, ME1
Genitsariotis, R; Hahn, M; Jung, M; Kiesslich, R; Mäurer, M; Nafe, B; Will, D1
Cottagnoud, M; Cottagnoud, P; Entenza, J; Flatz, L; Kühn, F; Stucki, A1
Hino, M; Iwata, Y; Kamimoto, A; Kinoshita, Y; Kobayashi, T; Oku, H; Yamane, T1
Alba, L; Antinori, A; Boumis, E; Festa, A; Marconi, P; Paglia, MG; Pucillo, LP; Visca, P1
Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I1
Abdulla, RH; Amsden, GW; Andrews, CP; de Caprariis, PJ; Knirsch, CA; Lode, H; Mandell, LA; McIvor, A; Niederman, MS; Vrooman, PS; Zervos, M1
González-Granda, D; Labrador, T; Martínez, I; Nieto, A; Querol-Borrás, JM; Querol-Ribelles, JM; Tenías, JM1
Burgess, DS; Frei, CR1
Kenton, I; McKinnon, PS; Mohr, JF; Okhuysen, PC; Peymann, PJ; Septimus, E1
Harnett, J; Matchar, DB; Samsa, GP; Wilson, J1
Asoh, N; Mizota, T; Nagatake, T; Oishi, K; Qin, L; Watanabe, H; Watanabe, K1
Erkin, G; Isik, SR; Kalyoncu, AF; Karakaya, G1
Aradhyula, S; Greisnauer, S; Manian, FA; Meyer, PL; Senkel, D; Setzer, J; Wiechens, M1
Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X1
Evers, T; Holman, A; Lloyd, A1
Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA1
Arvis, P; Carlet, J; Choudhri, S; Garau, J; Kureishi, A; Le Berre, MA; Lode, H; Read, RC; Torres, A; Winter, J1
Alsina, M; Calbo, E; Garau, J; Lite, J; Rodríguez-Carballeira, M1
Attridge, RT; Fisher, A; Frei, CR; Jaso, TC; Makos, BR; Mody, SH; Mortensen, EM; Oramasionwu, CU; Raut, MK; Restrepo, MI; Ruiz, AD; Ruiz, JL; Schein, JR1
Bielsa, S; Porcel, JM; Pubill-Fondevila, N1
Ge, X; Sun, H; Wang, H1
Coburn, B; Farrell, DJ; Jamieson, FB; Patel, SN; Rawte, P; Toye, B1
Hensel, DJ; Scurlock, AM; Woods, JL1
Bayne, CE; Davis, WA; Engel, JD; Rothstein, CP1
Chang, SJ; Hsieh, CH; Lin, CD; Yang, SS1
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS1
Baddour, LM; Kaufmann, BA; Kurz, M; Widmer, AF1
de la Guerra Acebal, C; Madariaga Ordeñana, I; Manterola Martija, JM; Moreno Rodrigo, A1
Huang, W; Jia, B; Liu, Y; Xiong, Y1
Adhikary, R; Bhattacharyya, A; Bishayi, B; Mahanti, S; Majhi, A1
Chang, FY; Chiu, CH; Lin, DY; Lin, HA; Lin, HC; Lin, JC; Wang, JX; Yang, YS; Yeh, KM1
Biscaro, V; Caruso, A; De Francesco, MA; Gargiulo, F; Piccinelli, G1
Adhikary, R; Bishayi, B; Mahanti, S; Majhi, A; Nandi, A1
Chen, TL; Chiu, CH; Fung, CP; Kuo, SC; Lee, YT; Lin, JC; Wang, FD; Wang, YC; Yang, YS; Yin, T1
Hsueh, PR; Huang, YT; Liao, CH; Liu, CY; Tsai, HY1
Fan, WG; Wang, L; Zhang, QS1
Jones, RN; Mendes, RE; Schuchert, JE1
Bonavila Juan, C; Goenaga Sánchez, MÁ; Michelena Bengoechea, A; Zubeltzu Sese, B1
Iino, N; Koda, R; Watanabe, H1
Ahmed, F; Barrow, R; Bornstein, M; Risley, JF; Simmons, S; Workowski, KA1
Deis, AS; Simpson, SQ; Whiles, BB1
Deguchi, T; Hatazaki, K; Ito, S; Kondo, H; Mizutani, K; Nakane, K; Nakano, M; Ohinishi, M; Shimuta, K; Tsuchiya, T; Yasuda, M; Yokoi, S1
Tsuchida, Y; Yoshida, N1
Judd, WR; Ratliff, PD; Wang, SS1
Fey, PD; Fowler, RC; Iwen, PC; Murphy, CN; Williams, AJ1
Dridi, B; Gingras, H; Leprohon, P; Ouellette, M1
Khalifa, MO; Mansour, MA1
Ansart, S; Gazeau, P; Quaesaet, L; Rezig, S; Tande, D; Williams, T1
Bulkow, L; Gordon, K; Stevens, R; Westley, B1
Boddu, SHS; Churchwell, MD; Mauro, VF; Ross, AR1
Lenart, KS; Ostorhazi, E; Szabo, BG; Tirczka, T1
Dadras, O; Dadsetan, B; Heidari, H; Izadi, M; Jafari, S; Mazaheri, E; Najafi, Z; SeyedAlinaghi, S; Voltarelli, F1
Funaishi, K; Hattori, N; Katsutani, S; Kawamoto, K; Matsumoto, N; Matsumoto, Y; Ohashi, N; Taniwaki, M; Yamasaki, M1
Marques, JG; Mouzinho, A; Oliveira, I1
Indriatmi, W; Nilasari, H; Prayogo, RL; Suseno, LS1
El-Ghanam, AM; Mahmoud, ME; Mohamed, RHA; Saad, SR1
Han, L; Ni, Y; Qu, J; Sun, J; Tao, Y; Xie, L; Xu, Y; Zhou, K1
Huang, H; Li, P; Liao, K; Liu, B; Liu, C; Su, W; Wang, Y; Zhou, Q1
Abolghasemi, S; Elyasi, F; Tehrani, S1
Chen, HC; Chen, KJ; Chen, YP; Chong, YJ; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wu, WC1
Bröring, U; Fischer, T; Juretzek, T; Preußer, D1
Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Lin, CN; Lin, CY; Liu, CP; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tang, HJ; Tsai, YT; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY1
Ahmad, A; Albert, A; Bird, B; Maheshwari, P; Patel, D1
Allen, GP; Deao, KM; Hill, SA; Schipelliti, SM; Tran, T1
Al Atbee, MYN; Jalil, MB1
Kiamos, A; Sands, M; Torrente, N; Verdecia, J1
Djilas, M; Marković, M; Milosavljević, B; Petrović, V; Ristić, M1
Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A1
Dong, J; Gao, Q; Han, Y; Song, J; Sun, N; Xu, S; Zou, W1
Fischer, T; Juretzek, T; Preußer, D1
Deng, L; Ding, Z; Li, K; Wang, J; Zhang, Q; Zhang, Y; Zhao, C1

Reviews

2 review(s) available for levofloxacin and ro13-9904

ArticleYear
Seminal vesicle abscess following prostate biopsy requiring transgluteal percutaneous drainage.
    The Canadian journal of urology, 2013, Volume: 20, Issue:3

    Topics: Abscess; Aged; Anti-Bacterial Agents; Buttocks; Ceftriaxone; Drainage; Escherichia coli; Escherichia coli Infections; Humans; Image-Guided Biopsy; Levofloxacin; Male; Nitrofurantoin; Prostate; Seminal Vesicles; Treatment Outcome; Ultrasound, High-Intensity Focused, Transrectal

2013
[Recurrent endocarditis due to Brevibacterium casei: case presentation and a review of the literature].
    Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:2

    Topics: Actinomycetales Infections; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Brevibacterium; Ceftriaxone; Disease Susceptibility; Drug Therapy, Combination; Emergencies; Endocarditis, Bacterial; Facial Dermatoses; Gentamicins; Humans; Levofloxacin; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Recurrence; Tetracycline; Vancomycin; Wound Infection

2017

Trials

19 trial(s) available for levofloxacin and ro13-9904

ArticleYear
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prodrugs; Prospective Studies; Treatment Outcome

1997
A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia.
    Scandinavian journal of infectious diseases, 1998, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitalization; Humans; International Cooperation; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome

1998
[Levofloxacin in the treatment of community-acquired pneumococcal pneumonia].
    Presse medicale (Paris, France : 1983), 1999, Nov-20, Volume: 28, Issue:36

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Clavulanic Acid; Community-Acquired Infections; Drug Therapy, Combination; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal

1999
[Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization].
    Medicina clinica, 2000, Nov-04, Volume: 115, Issue:15

    Topics: Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies

2000
A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia.
    Clinical therapeutics, 2002, Volume: 24, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Severity of Illness Index

2002
[Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:1

    Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacteriological Techniques; Bile; Ceftriaxone; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Data Interpretation, Statistical; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Levofloxacin; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Time Factors

2003
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
    Treatments in respiratory medicine, 2004, Volume: 3, Issue:5

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Azithromycin; Canada; Ceftriaxone; Community-Acquired Infections; Drug Administration Schedule; Female; Germany; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Severity of Illness Index; Treatment Outcome; United States

2004
Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    International journal of antimicrobial agents, 2005, Volume: 25, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome

2005
A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Chest, 2005, Volume: 128, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Costs and Cost Analysis; Drug Therapy, Combination; Female; Home Care Services; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; United States

2005
Short report: antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including beta-lactamase-negative ampicillin-resistant strains.
    Epidemiology and infection, 2007, Volume: 135, Issue:4

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Respiratory Tract Infections

2007
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:10

    Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome

2007
A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial.
    Current medical research and opinion, 2008, Volume: 24, Issue:5

    Topics: Administration, Oral; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Cost of Illness; Cost-Benefit Analysis; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Hospitalization; Humans; Infusions, Intravenous; Length of Stay; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Severity of Illness Index; Treatment Outcome

2008
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Severity of Illness Index; Treatment Outcome

2008
Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cytokines; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukins; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal; Prospective Studies; Time Factors; Tumor Necrosis Factor-alpha

2008
Are prophylactic antibiotics necessary in patients with preoperative sterile urine undergoing ureterorenoscopic lithotripsy?
    BJU international, 2014, Volume: 113, Issue:2

    Topics: Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Cefazolin; Ceftriaxone; Double-Blind Method; Female; Fever; Humans; Levofloxacin; Lithotripsy; Male; Middle Aged; Odds Ratio; Postoperative Complications; Practice Guidelines as Topic; Preoperative Care; Prospective Studies; Pyuria; Treatment Outcome; Ureteroscopy; Urinary Tract Infections

2014
Male Paraurethral Duct Infection and Subsequent Paraurethral Duct Dilation.
    Chinese medical journal, 2015, Nov-20, Volume: 128, Issue:22

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Humans; Levofloxacin; Male; Middle Aged; Nitrofurantoin; Urethra; Urethral Diseases; Young Adult

2015
Antibiotic prophylaxis in transarterial chemoembolization of hepatocellular carcinoma.
    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2018, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Catheterization, Peripheral; Ceftriaxone; Chemoembolization, Therapeutic; Ciprofloxacin; Drug Administration Routes; Drug Monitoring; Egypt; Female; Humans; Levofloxacin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Treatment Outcome

2018
Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
    Recent patents on anti-infective drug discovery, 2018, Volume: 13, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Asia; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Pneumonia; Prospective Studies; Treatment Outcome

2018
Levofloxacin Versus Ceftriaxone for the Treatment of Acute Pyelonephritis in Iranian Adults.
    Infectious disorders drug targets, 2021, Volume: 21, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Humans; Iran; Levofloxacin; Pyelonephritis; Urinary Tract Infections

2021

Other Studies

63 other study(ies) available for levofloxacin and ro13-9904

ArticleYear
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Clarithromycin; Cohort Studies; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; United States

1997
Antimicrobial susceptibility of viridans group streptococci.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin

1997
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae

1999
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:6

    Topics: Animals; Anti-Infective Agents; Catheterization; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rats; Streptococcal Infections; Streptococcus; Streptococcus sanguis; Treatment Outcome

1999
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia.
    Infection control and hospital epidemiology, 2000, Volume: 21, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Enterococcus; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Vancomycin Resistance

2000
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
    Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; United States

2002
Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Culture Media; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Quinolines; Selection, Genetic; Streptococcus pneumoniae

2002
[Rupture of the Achilles' tendon secondary to levofloxacin].
    Gastroenterologia y hepatologia, 2003, Volume: 26, Issue:1

    Topics: Achilles Tendon; Adult; Ceftriaxone; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Humans; Intestinal Perforation; Levofloxacin; Male; Methylprednisolone; Metronidazole; Ofloxacin; Rupture; Tendinopathy

2003
Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Drug Synergism; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae

2004
[A case of pseudothrombocytopenia during antibiotic administration].
    Rinsho byori. The Japanese journal of clinical pathology, 2004, Volume: 52, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Fatal Outcome; Female; Humans; Levofloxacin; Lung Diseases, Interstitial; Ofloxacin; Thrombocytopenia

2004
Short Communication: Yersinia pseudotuberculosis septicemia in an HIV-infected patient failed HAART.
    AIDS research and human retroviruses, 2004, Volume: 20, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Ceftriaxone; Drug Therapy, Combination; Female; Humans; Levofloxacin; Ofloxacin; Sepsis; Treatment Failure; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections

2004
E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach.
    The new microbiologica, 2004, Volume: 27, Issue:3

    Topics: Anemia; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cost-Benefit Analysis; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Hematologic Neoplasms; Humans; Levofloxacin; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections

2004
Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.
    Pharmacotherapy, 2005, Volume: 25, Issue:9

    Topics: Anti-Bacterial Agents; Area Under Curve; Ceftriaxone; Computer Simulation; Databases, Factual; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intravenous; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Ofloxacin; Streptococcus pneumoniae

2005
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
    Pharmacotherapy, 2005, Volume: 25, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Ceftriaxone; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Middle Aged; Ofloxacin; Product Surveillance, Postmarketing; Retrospective Studies

2005
Multidrug-induced erythema multiforme.
    Journal of investigational allergology & clinical immunology, 2007, Volume: 17, Issue:3

    Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Hypersensitivity; Erythema Multiforme; Female; Humans; Levofloxacin; Methenamine; Ofloxacin; Piroxicam; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2007
Is it Clostridium difficile infection or something else? A case-control study of 352 hospitalized patients with new-onset diarrhea.
    Southern medical journal, 2007, Volume: 100, Issue:8

    Topics: Aged; Analysis of Variance; Case-Control Studies; Cefazolin; Ceftriaxone; Clostridioides difficile; Confidence Intervals; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Levofloxacin; Male; Missouri; Multivariate Analysis; Odds Ratio; Ofloxacin; Regression Analysis; Retrospective Studies; Risk Factors

2007
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand

2008
Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
    Current medical research and opinion, 2009, Volume: 25, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Female; Health Resources; Humans; Least-Squares Analysis; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Practice Guidelines as Topic; Societies, Medical; United States

2009
[Levofloxacin hepatotoxicity].
    Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6

    Topics: Adult; Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Bronchiectasis; Bronchitis; Ceftriaxone; Chemical and Drug Induced Liver Injury; Drug Substitution; gamma-Glutamyltransferase; Hepatomegaly; Humans; Hyperbilirubinemia; Levofloxacin; Male; Ofloxacin

2013
Simultaneous determination of the combined drugs of ceftriaxone sodium, metronidazole, and levofloxacin in human urine by high-performance liquid chromatography.
    Journal of clinical laboratory analysis, 2012, Volume: 26, Issue:6

    Topics: Ceftriaxone; Chromatography, High Pressure Liquid; Ethylamines; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Levofloxacin; Methanol; Metronidazole; Ofloxacin; Phosphates; Potassium Compounds; Reproducibility of Results; Sensitivity and Specificity

2012
Antimicrobial susceptibilities of clinical isolates of HACEK organisms.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Anti-Bacterial Agents; Ceftriaxone; Gram-Negative Bacteria; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin

2013
Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
    Pediatric emergency care, 2013, Volume: 29, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Arkansas; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Child; Diagnosis, Differential; Diagnostic Errors; Doxycycline; Ethnicity; Female; Guideline Adherence; Humans; International Classification of Diseases; Levofloxacin; Metronidazole; Ofloxacin; Outpatient Clinics, Hospital; Pain; Pelvic Inflammatory Disease; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Sexually Transmitted Diseases; Symptom Assessment; United States; Uterine Cervicitis; Young Adult

2013
Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4

    Topics: Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination

2014
Propionibacterium acnes prosthetic valve endocarditis with abscess formation: a case report.
    BMC infectious diseases, 2014, Feb-25, Volume: 14

    Topics: Abscess; Adult; Anti-Bacterial Agents; Ceftriaxone; Communicable Diseases; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Levofloxacin; Male; Middle Aged; Propionibacterium acnes; Prosthesis-Related Infections; Rifampin; Treatment Outcome

2014
[Young male with fever and muscle pain after a visit to the dentist].
    Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Clindamycin; Combined Modality Therapy; Dental Prophylaxis; Diagnosis, Differential; Fasciotomy; Fever; Humans; Levofloxacin; Male; Mobility Limitation; Mouth; Muscle, Skeletal; Myalgia; Myositis; Rhabdomyolysis; Running; Streptococcus sanguis

2014
Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B.
    Annals of clinical microbiology and antimicrobials, 2014, May-12, Volume: 13

    Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Coinfection; Drug Resistance, Bacterial; Hepatitis A; Hepatitis A virus; Hepatitis B, Chronic; Humans; Levofloxacin; Male; Paratyphoid Fever; Recurrence; Salmonella paratyphi A

2014
Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Male; Mice; Mice, Inbred BALB C; N-Acetylmuramoyl-L-alanine Amidase; Pneumococcal Infections; Pneumonia; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Streptolysins; Virulence; Virulence Factors

2014
Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Costs and Cost Analysis; Ertapenem; Escherichia coli; Female; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult

2016
Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2015, Volume: 34

    Topics: Anti-Bacterial Agents; Cefaclor; Ceftriaxone; Cefuroxime; Disk Diffusion Antimicrobial Tests; DNA Gyrase; Drug Resistance, Bacterial; Erythromycin; Humans; Levofloxacin; Penicillins; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Urinary Tract Infections

2015
In vitro susceptibility of a penicillin-resistant and tolerable isolate of Streptococcus pneumoniae to combination therapy.
    Journal of infection in developing countries, 2015, Jul-30, Volume: 9, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Drug Synergism; Drug Tolerance; Humans; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Pneumococcal Infections; Streptococcus pneumoniae

2015
A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii.
    BMC infectious diseases, 2015, Sep-30, Volume: 15

    Topics: Acinetobacter; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftazidime; Ceftriaxone; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Incidence; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Retrospective Studies; RNA, Ribosomal, 16S

2015
In vitro synergy of penicillin, ceftriaxone and levofloxacin against serotype 19A Streptococcus pneumoniae.
    International journal of antimicrobial agents, 2015, Volume: 46, Issue:6

    Topics: Anti-Bacterial Agents; Ceftriaxone; Drug Synergism; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Serogroup; Streptococcus pneumoniae

2015
Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae; Teicoplanin; Vancomycin

2016
Mycotic Aneurysm of the Abdominal Aorta Complicated With Iliopsoas Abscess and Infectious Spondylodiscitis in a Long-Term Hemodialyzed Patient: A Rare but Serious Complication of Staphylococcus Aureus Bacteremia.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2016, Volume: 20, Issue:6

    Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Bacteremia; Cefazolin; Ceftriaxone; Discitis; Drainage; Humans; Levofloxacin; Male; Middle Aged; Psoas Abscess; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus

2016
Factors Associated With Primary Care Physician Knowledge of the Recommended Regimen for Treating Gonorrhea.
    Sexually transmitted diseases, 2017, Volume: 44, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Chi-Square Distribution; Clinical Protocols; Drug Therapy, Combination; Female; Gonorrhea; Health Knowledge, Attitudes, Practice; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Physicians, Primary Care; Practice Patterns, Physicians'; Primary Health Care; Spectinomycin

2017
Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients.
    Critical care medicine, 2017, Volume: 45, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Comorbidity; Disease Progression; Female; Hospital Mortality; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Time Factors; Time-to-Treatment; Vasoconstrictor Agents

2017
Haemophilus influenzae Isolated From Men With Acute Urethritis: Its Pathogenic Roles, Responses to Antimicrobial Chemotherapies, and Antimicrobial Susceptibilities.
    Sexually transmitted diseases, 2017, Volume: 44, Issue:4

    Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Coinfection; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Haemophilus influenzae; Humans; Leukocyte Count; Levofloxacin; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Retrospective Studies; Urethritis

2017
Palm atheroma infection caused by
    BMJ case reports, 2017, Nov-04, Volume: 2017

    Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Drainage; Enterobacteriaceae; Enterobacteriaceae Infections; Hand; Humans; Levofloxacin; Male; Plaque, Atherosclerotic

2017
Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections.
    International journal of clinical pharmacy, 2018, Volume: 40, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections

2018
Nontyphoidal Salmonella enterica Nonsusceptible to Both Levofloxacin and Ceftriaxone in Nebraska, United States 2014-2015.
    Foodborne pathogens and disease, 2018, Volume: 15, Issue:4

    Topics: Anti-Bacterial Agents; Ceftriaxone; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Nebraska; Quinolones; Salmonella enterica; Sequence Analysis, DNA; Serotyping; Specimen Handling

2018
Coupling next-generation sequencing to dominant positive screens for finding antibiotic cellular targets and resistance mechanisms in Escherichia coli.
    Microbial genomics, 2018, Volume: 4, Issue:2

    Topics: Anti-Bacterial Agents; Ceftriaxone; CRISPR-Cas Systems; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Knockdown Techniques; Genes, Bacterial; Gentamicins; High-Throughput Nucleotide Sequencing; Levofloxacin; Membrane Proteins; Microbial Sensitivity Tests; Plasmids; R Factors; Tetracycline; Transcription Factors; Trimethoprim

2018
Erysipelothrix rhusiopathiae knee prosthesis infection.
    Medecine et maladies infectieuses, 2018, Volume: 48, Issue:5

    Topics: Aged, 80 and over; Amoxicillin; Arthroplasty, Replacement, Knee; Ceftriaxone; Chemical and Drug Induced Liver Injury; Drug Substitution; Erysipelothrix; Erysipelothrix Infections; Humans; Knee Prosthesis; Levofloxacin; Male; Prosthesis-Related Infections; Recurrence; Reoperation; Sepsis

2018
Impact of an antimicrobial stewardship program on outcomes in patients with community-acquired pneumonia admitted to a tertiary community hospital.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018, Jun-01, Volume: 75, Issue:11 Supplem

    Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Ceftriaxone; Community-Acquired Infections; Female; Hospitals, Community; Humans; Length of Stay; Levofloxacin; Male; Pneumonia, Bacterial; Retrospective Studies; Tertiary Care Centers; Treatment Outcome

2018
Physical compatibility of milrinone with levofloxacin and ceftriaxone injection.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018, 07-15, Volume: 75, Issue:14

    Topics: Anti-Bacterial Agents; Cardiotonic Agents; Ceftriaxone; Drug Compounding; Drug Incompatibility; Glucose; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Levofloxacin; Milrinone

2018
Clinical and microbiological characteristics of adult invasive Haemophilus influenzae infections: results of a 14-year single-center experience from Hungary.
    Infection, 2018, Volume: 46, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Hungary; Incidence; Levofloxacin; Male; Middle Aged; Retrospective Studies; Sepsis

2018
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report.
    Annals of hematology, 2019, Volume: 98, Issue:8

    Topics: Aged; Anti-Bacterial Agents; Antibody Specificity; Antifungal Agents; Autoantibodies; Autoimmune Diseases; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Substitution; Drug Therapy, Combination; Factor V; Factor V Deficiency; Fluoroquinolones; Humans; Levofloxacin; Male; Meropenem; Micafungin; Partial Thromboplastin Time; Pneumonia; Prothrombin Time

2019
Gonococcal orbital cellulitis.
    BMJ case reports, 2019, Jul-23, Volume: 12, Issue:7

    Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Coitus; Conjunctivitis, Bacterial; Gonorrhea; Humans; Levofloxacin; Male; Neisseria gonorrhoeae; Orbital Cellulitis; Photophobia; Treatment Outcome

2019
Antimicrobial resistance of Neisseria gonorrhoeae in Jakarta, Indonesia: a cross-sectional study.
    Sexual health, 2020, Volume: 17, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Indonesia; Levofloxacin; Male; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline

2020
Enhanced adsorption of Levofloxacin and Ceftriaxone antibiotics from water by assembled composite of nanotitanium oxide/chitosan/nano-bentonite.
    Materials science & engineering. C, Materials for biological applications, 2020, Volume: 108

    Topics: Adsorption; Bentonite; Ceftriaxone; Chitosan; Kinetics; Levofloxacin; Nanocomposites; Titanium; Water

2020
Emerging coexistence of three PMQR genes on a multiple resistance plasmid with a new surrounding genetic structure of qnrS2 in E. coli in China.
    Antimicrobial resistance and infection control, 2020, 04-15, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Genome Size; Levofloxacin; Microbial Sensitivity Tests; Mutation; Plasmids; Whole Genome Sequencing

2020
Pithecellobium clypearia extract enriched in gallic acid and luteolin has antibacterial activity against MRSA and reduces resistance to erythromycin, ceftriaxone sodium and levofloxacin.
    Journal of applied microbiology, 2020, Volume: 129, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Fabaceae; Gallic Acid; Levofloxacin; Luteolin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Plant Extracts; Staphylococcal Infections; Tandem Mass Spectrometry

2020
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes.
    Scientific reports, 2021, 03-18, Volume: 11, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; Cefuroxime; Corneal Ulcer; Endophthalmitis; Eye Enucleation; Eye Injuries; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillins; Pneumococcal Infections; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Taiwan; Tertiary Care Centers; Trabeculectomy; Treatment Outcome; Vancomycin; Vitrectomy

2021
Effects of antibiotics ceftriaxone and levofloxacin on the growth of Calliphora vomitoria L. (Diptera: Calliphoridae) and effects on the determination of the post-mortem interval.
    Journal of forensic and legal medicine, 2021, Volume: 81

    Topics: Animals; Anti-Bacterial Agents; Calliphoridae; Ceftriaxone; Forensic Entomology; Larva; Levofloxacin; Postmortem Changes

2021
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2022, Volume: 55, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Levofloxacin; Linezolid; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Taiwan; Vancomycin

2022
Bacillus pumilus-Borne Food Poisoning in an Immunosuppressed Host.
    The American journal of medicine, 2021, Volume: 134, Issue:12

    Topics: Anti-Bacterial Agents; Bacillus pumilus; Ceftriaxone; Doxycycline; Foodborne Diseases; Gastroenteritis; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunosuppression Therapy; Kidney Transplantation; Levofloxacin; Male; Middle Aged; MTOR Inhibitors; Pancreas Transplantation

2021
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; Ertapenem; Gentamicins; Gonorrhea; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Neisseria gonorrhoeae

2021
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
    Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:9

    Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2022
Right hip gonococcal septic arthritis treatment with successful transition to oral fluoroquinolone.
    BMJ case reports, 2022, Sep-16, Volume: 15, Issue:9

    Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Levofloxacin; Tetracycline

2022
Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carrier State; Ceftriaxone; Child; COVID-19; Delivery of Health Care; Erythromycin; Female; Humans; Infant; Levofloxacin; Middle Aged; Nasopharynx; Outpatients; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Serbia; Serogroup; Streptococcus pneumoniae; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Genotypic Detection of
    Archives of Razi Institute, 2022, Volume: 77, Issue:2

    Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections

2022
A case report of acute suppurative thyroiditis caused by
    Future microbiology, 2023, Volume: 18

    Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Clostridium perfringens; Female; Humans; Levofloxacin; Thyroiditis, Suppurative

2023
Effects of antibiotics ceftriaxone and levofloxacin on the growth of Lucilia sericata (Diptera: Calliphoridae).
    Medical and veterinary entomology, 2023, Volume: 37, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Calliphoridae; Ceftriaxone; Diptera; Humans; Larva; Levofloxacin

2023
Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis.
    Drug design, development and therapy, 2023, Volume: 17

    Topics: Brucellosis; Ceftriaxone; Doxycycline; Humans; Inflammation; Levofloxacin; Low Back Pain; Lumbar Vertebrae; Retrospective Studies; Rifampin; Spondylitis; Treatment Outcome

2023